Cargando…

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial

Association of HIV-1–specific T-cell responses to infection risk in seronegative individuals is controversial. We quantified and phenotypically characterized gp120-specific T-cell responses in HIV-1 exposed, but uninfected subjects enrolled in the global Pre-exposure Prophylaxis Initiative (iPrEx) c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuebler, Peter J., Shaw, Brian I., Leadabrand, Kaitlyn S., Mehrotra, Megha L., Grant, Robert M., Kallás, Esper G., Nixon, Douglas F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395050/ https://www.ncbi.nlm.nih.gov/pubmed/26674373 http://dx.doi.org/10.1097/QAI.0000000000000923

Ejemplares similares

HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
por: Deutsch, Madeline B., et al.
Publicado: (2015)

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial
por: Liegler, Teri, et al.
Publicado: (2014)

No Evidence of Sexual Risk Compensation in the iPrEx Trial of Daily Oral HIV Preexposure Prophylaxis
por: Marcus, Julia L., et al.
Publicado: (2013)

Role of the pharmacist in pre-exposure chemoprophylaxis (PrEP) therapy for HIV prevention
por: Clauson, Kevin A., et al.
Publicado: (2009)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
por: Baird, J Kevin
Publicado: (2021)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
por: Moss, Emaya M., et al.
Publicado: (2023)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Internalization and Axonal Transport of the HIV Glycoprotein gp120
por: Berth, Sarah, et al.
Publicado: (2015)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
por: Drummer, Heidi E., et al.
Publicado: (2013)

Chemoprophylaxis in Medicine and Surgery
por: O'Grady, F. W.
Publicado: (1972)

Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 ± IL-15
por: McKee, Hayley J, et al.
Publicado: (2004)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

NMR spectroscopy of HIV-1 gp120 outer domain
por: Sastry, M, et al.
Publicado: (2012)

Behavioral Evidence for a Tau and HIV-gp120 Interaction
por: Vijayan, Murali, et al.
Publicado: (2022)

Structural Basis for Species Selectivity in the HIV-1 gp120-CD4 Interaction: Restoring Affinity to gp120 in Murine CD4 Mimetic Peptides
por: Kassler, Kristin, et al.
Publicado: (2011)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
por: Sanders, Rogier W, et al.
Publicado: (2004)

Doxycycline for Malaria Chemoprophylaxis and Treatment: Report from the CDC Expert Meeting on Malaria Chemoprophylaxis
por: Tan, Kathrine R., et al.
Publicado: (2011)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
por: Visciano, Maria Luisa, et al.
Publicado: (2008)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity
por: Mathys, Leen, et al.
Publicado: (2014)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Chemoprophylaxis and Malaria Death Rates
por: Krause, Gérard, et al.
Publicado: (2006)

Chemoprophylaxis of Tropical Infectious Diseases
por: McBride, William J. H.
Publicado: (2010)

HLA-C increases HIV-1 infectivity and is associated with gp120
por: Matucci, Andrea, et al.
Publicado: (2008)

The C5 region of HIV-1 gp120 binds specific
por: Dalgleish, A, et al.
Publicado: (2006)

Nitric oxide protects against HIV gp120 endothelial injury
por: Fiorucci, S, et al.
Publicado: (2010)

Structural Plasticity and Conformational Transitions of HIV Envelope Glycoprotein gp120
por: Korkut, Anil, et al.
Publicado: (2012)

Gp120 on HIV-1 Virions Lacks O-Linked Carbohydrate
por: Stansell, Elizabeth, et al.
Publicado: (2015)

Helix-A peptide prevents gp120-mediated neuronal loss
por: Avdoshina, Valeria, et al.
Publicado: (2019)

Amyloidogenic, neuroinflammatory and memory dysfunction effects of HIV-1 gp120
por: Lee, Young-Jung, et al.
Publicado: (2021)

Recent Advances in the Molecular and Cellular Mechanisms of gp120-Mediated Neurotoxicity
por: Avdoshina, Valeria, et al.
Publicado: (2022)

Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists
por: Curreli, Francesca, et al.
Publicado: (2022)

Correction: Deletion of the Highly Conserved N-Glycan at Asn260 of HIV-1 gp120 Affects Folding and Lysosomal Degradation of gp120, and Results in Loss of Viral Infectivity
Publicado: (2014)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α(4)β(7)
por: Lertjuthaporn, Sakaorat, et al.
Publicado: (2018)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Retraction: Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector
Publicado: (2020)

HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA
por: Shah, Ankit, et al.
Publicado: (2010)

HIV-1 gp120 Induces Expression of IL-6 through a Nuclear Factor-Kappa B-Dependent Mechanism: Suppression by gp120 Specific Small Interfering RNA
por: Shah, Ankit, et al.
Publicado: (2011)

Rate and affinity binding constants determined by SPR spectroscopy reveal differential antigenicity of HIV gp120 and gp140
por: Gearhart, TL, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_37usgpoilku9iu4kj9p0n859ob